Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody.

Kerman, R H; Katz, S M; Van Buren, C T; Garcia, C; Kahan, B D

Kerman, R H; Katz, S M; Van Buren, C T; Garcia, C; Kahan, B D.

Affiliation

Kerman RH; University of Texas Medical School, Houston, Texas, USA.

Transplant Proc ; 33(1-2): 401, 2001.

Article in En | MEDLINE | ID: mdl-11266881

Subject(s)

Graft Rejection/prevention & control; HLA Antigens/immunology; Immunoglobulin G/drug effects; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/immunology; Sirolimus/therapeutic use; Cyclosporine/therapeutic use; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Graft Rejection/immunology; Humans; Immunoglobulin G/analysis; Prednisone/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Kidney Transplantation / Sirolimus / Graft Rejection / HLA Antigens / Immunosuppressive Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links